HUM vs LAB
Humana Inc (HUM) versus Standard Biotools Inc (LAB) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Latest reported HUM revenue for 2024-12-31 was $117.76B. Net income was $1.21B. Revenue was up 10.7% from 2023-12-31 to 2024-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. LAB currently screens at market cap $317.1M.
Not investment advice. Open the HUM and LAB stock pages for the full models.
Not investment advice.